- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07740629
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety? (VIDEO-U)
Use of a Pre-Procedure Educational Video for Urodynamic Testing as a Tool to Reduce Anxiety: A Prospective Randomized Study
The objective of this randomized prospective study is to evaluate whether viewing an educational video before urodynamic testing reduces anxiety among women undergoing evaluation for pelvic floor or urinary symptoms.
The primary research question is: Does viewing a short educational video before urodynamic testing reduce objective and subjective anxiety levels and improve the overall testing experience? Participants scheduled to undergo urodynamic testing as part of routine clinical care will be randomly assigned to either an educational video intervention or standard pre-procedure counseling alone. Participants will complete brief questionnaires, provide saliva samples for cortisol measurement as an objective biomarker of stress, and report anxiety and pain levels before, during, and after urodynamic testing.
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
his study examines whether viewing a short educational video before urodynamic testing reduces anxiety, embarrassment, and discomfort, and improves participants' understanding of the procedure. Urodynamic testing evaluates bladder and urethral sphincter function, and many women experience stress before undergoing the examination. Eligible participants are women whose treating physician has recommended urodynamic testing as part of the evaluation of urinary or pelvic floor symptoms. Participation in the study is entirely voluntary.
Following informed consent, participants will meet with a member of the research team, who will explain the purpose of the study and the urodynamic procedure. Participants will then be randomly assigned to either an educational video intervention group or a standard verbal explanation group. Before the procedure, participants will complete brief questionnaires assessing stress level, coping style, and demographic and clinical characteristics. A saliva sample will be collected for cortisol measurement as an objective biomarker of stress, and blood pressure and heart rate will be recorded.
During urodynamic testing, participants will rate anxiety and pain using a numerical rating scale from 1 to 10, and an additional saliva sample will be collected. After completion of the examination, participants will complete a brief questionnaire evaluating the overall experience, including anxiety, embarrassment, and discomfort. The total duration of study-related procedures, including urodynamic testing, is approximately one hour.
No additional medical risks are anticipated beyond those associated with standard urodynamic testing. Some participants may experience minor discomfort when answering personal questions or providing saliva samples. No additional procedural risks are expected. Although individual benefit cannot be guaranteed, participation may improve preparation for urodynamic testing and reduce anxiety or discomfort. The knowledge gained from this study may contribute to improving the care of future patients undergoing urodynamic evaluation.
All study data will be coded and maintained confidentially to protect participant privacy. Access to identifiable information will be limited to the investigators and authorized regulatory authorities, in accordance with applicable regulations. No identifying information will appear in reports or publications. Participation is voluntary, and participants may decline participation or withdraw from the study at any time without affecting current or future medical care.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: yair daykan, Dr
- Numéro de téléphone: +972542198231
- E-mail: yair.dykan@gmail.com
Lieux d'étude
-
-
Israel
-
Kfar Saba, Israel, Israël, 11125
- Recrutement
- Meir Medical Center
-
Contact:
- Yair M Daykan, MD
- Numéro de téléphone: 972-54-2198231
- E-mail: yair.dykan@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- women 18 years and above, undergoing a urodynamics test
Exclusion Criteria:
- women under SSRI/SNRI treatment women with a known anxiety disorder women who had a previous urodynamics test
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Study group- video
Participants in the intervention arm will watch a short educational video explaining the purpose, steps, and sensations expected during urodynamic testing.
They will then undergo the standard urodynamic procedure.
Anxiety will be assessed using questionnaires and saliva cortisol samples before, during, and after the test, along with self-reported pain and discomfort levels.Video before urodynamics; anxiety measured by surveys and cortisol.
|
A short video explaining the urodynamics test.
|
|
Aucune intervention: Control group- No video
Participants in the control arm will receive the standard verbal explanation routinely provided before urodynamic testing, without viewing the educational video.
They will then undergo the same assessments as the intervention group, including questionnaires, saliva cortisol collection, and self-reported measures of anxiety, pain, and discomfort at the same time points.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Anxiety represented by cortisol levels
Délai: through study completion, an average of 1 hour
|
Comparison between levels of salivary cortisol concentrations before and at the end of the urodynamics test, between the two groups.
Cortisol level in nmol/L .
the higher difference show increase in stress level
|
through study completion, an average of 1 hour
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Heart rate and subjective questionnaires
Délai: through study completion, an average of 1 hour
|
Comparison between levels of heart rate and subjective anxiety level questionnaire scores, before and during the urodynamics test, between the two groups.
|
through study completion, an average of 1 hour
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies urogénitales masculines
- Maladies urologiques
- Maladies urogénitales féminines
- Maladies urogénitales féminines et complications de la grossesse
- Troubles urinaires
- Symptômes des voies urinaires inférieures
- Manifestations urologiques
- Maladies de la vessie urinaire
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Incontinence urinaire
- Incontinence urinaire, Stress
- Vessie urinaire, hyperactive
- Technologie, industrie et agriculture
- Technologie
- Enregistrement de bande
- SIDA audiovisuelle
- Technologie éducative
- Télévision
- Enregistrement vidéo
Autres numéros d'identification d'étude
- 0210-20-MMC
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .